Literature DB >> 7884759

One laparoscopic puncture for treatment of ovarian cysts with adnexal torsion in early pregnancy. A report of two cases.

S Garzarelli1, N Mazzuca.   

Abstract

In two cases a simple laparoscopic technique was used to treat ovarian cysts with adnexal torsion in early pregnancy. A single laparoscopic route was sufficient. This procedure has great value for girls and young women for whom the preservation of fertility is a major concern.

Entities:  

Mesh:

Year:  1994        PMID: 7884759

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  5 in total

1.  Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy: this statement was reviewed and approved by the Board of Governors of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), September 2007. It was prepared by the SAGES Guidelines Committee.

Authors:  Hori Yumi
Journal:  Surg Endosc       Date:  2008-02-21       Impact factor: 4.584

Review 2.  Diagnosis and laparoscopic treatment of surgical diseases during pregnancy: an evidence-based review.

Authors:  Heidi Jackson; Steven Granger; Raymond Price; Michael Rollins; David Earle; William Richardson; Robert Fanelli
Journal:  Surg Endosc       Date:  2008-06-14       Impact factor: 4.584

3.  Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy.

Authors:  Jonathan Pearl; Raymond Price; William Richardson; Robert Fanelli
Journal:  Surg Endosc       Date:  2011-09-23       Impact factor: 4.584

4.  SAGES guidelines for the use of laparoscopy during pregnancy.

Authors:  Jonathan P Pearl; Raymond R Price; Allison E Tonkin; William S Richardson; Dimitrios Stefanidis
Journal:  Surg Endosc       Date:  2017-06-22       Impact factor: 4.584

Review 5.  Laparoscopy during pregnancy: a literature review.

Authors:  F R Nezhat; S Tazuke; C H Nezhat; D S Seidman; D R Phillips; C R Nezhat
Journal:  JSLS       Date:  1997 Jan-Mar       Impact factor: 2.172

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.